Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Melatonin  COVID-19 treatment studies for Melatonin  C19 studies: Melatonin  Melatonin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19
Reiter et al., Frontiers in Medicine, doi:10.3389/fmed.2020.00226 (Review)
Reiter et al., Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19, Frontiers in Medicine, doi:10.3389/fmed.2020.00226 (Review)
May 2020   Source   PDF  
  All Studies   Meta
Review of melatonin's action as an antiinflammatory, antioxidant, and antiviral (against other viruses) agent, and proposed therapeutic algorithm for use with COVID-19.
Reiter et al., 15 May 2020, peer-reviewed, 4 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperMelatoninAll
Abstract: MINI REVIEW published: 15 May 2020 doi: 10.3389/fmed.2020.00226 Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19 Russel J. Reiter 1*, Pedro Abreu-Gonzalez 2 , Paul E. Marik 3 and Alberto Dominguez-Rodriguez 4,5,6* 1 Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX, United States, 2 Department of Physiology, Faculty of Medicine, University of La Laguna, San Cristóbal de La Laguna, Spain, 3 Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA, United States, 4 Department of Cardiology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 5 Facultad de Ciencias de la Salud, Universidad Europea de Canarias, Santa Cruz de Tenerife, Spain, 6 CIBER de enfermedades CardioVasculares (CIBERCV), Madrid, Spain Edited by: Zisis Kozlakidis, International Agency for Research on Cancer (IARC), France Reviewed by: Irene Crespo, University of León, Spain Abdul Alim Al-Bari, University of Rajshahi, Bangladesh Javier González-Gallego, University of León, Spain *Correspondence: Russel J. Reiter Alberto Dominguez-Rodriguez Specialty section: This article was submitted to Infectious Diseases – Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine Received: 06 April 2020 Accepted: 04 May 2020 Published: 15 May 2020 Citation: Reiter RJ, Abreu-Gonzalez P, Marik PE and Dominguez-Rodriguez A (2020) Therapeutic Algorithm for Use of Melatonin in Patients With COVID-19. Front. Med. 7:226. doi: 10.3389/fmed.2020.00226 Frontiers in Medicine | The coronavirus, COVID-19, has infected hundreds of thousands and killed tens of thousands of individuals worldwide. This highly infectious condition continues to ravage the world population and has yet to reach it peak infective rate in some countries. Many conventional drugs including hydroxychloroquine/chloroquine, lopinavir, remdesivir, etc., have been repurposed as treatments for this often deadly disease, but there is no specifically-designed effective drug available; also, the drugs mentioned have significant side effects and their efficacy is unknown. New drugs and vaccines are being designed as COVID-19 treatment, but their development and testing will require months to years. Time is not a luxury that this crisis has. Thus, there is a serious unmet need for the identification of currently-available and safe molecules which can be used to slow or treat COVID-19 disease. Here, we suggest melatonin be given consideration for prophylactic use or treatment alone or in combination with other drugs. Melatonin’s multiple actions as an anti-inflammatory, anti-oxidant, and anti-viral (against other viruses) make it a reasonable choice for use. Melatonin is readily available, can be easily synthesized in large quantities, is inexpensive, has a very high safety profile and can be easily self-administered. Melatonin is endogenously-produced molecule in small amounts with its production diminishing with increased age. Under the current critical conditions, large doses of melatonin alone or in combination with currently-recommended drugs, e.g., hydroxychloroquine/chloroquine, to resist COVID-19 infection would seem judicious. Keywords: melatonin, COVID-19, SARS-CoV-2, treatment-drug, prevention & control
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop